Peter Czermak, Ph.D.

University of Applied Sciences Mittelhessen

hMSC Production in Disposable Bioreactors in Compliance with cGMP Guidelines and PAT
Friday, April 25, 2014
Cell-based therapies continue to gain more and more importance within the multibillion-dollar market of biopharmaceutical products and continue to exemplify above-average growth possibilities [1-5]. Stem cells in particular ... read more